trial

Involuntary Memories Investigation in Schizophrenia

NCTId NCT03209778
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 65 (actual)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2019-12-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
65 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2017-09-29
Primary completion
2019-12-15
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Patients with Schizophrenia

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
65
Phase
NA
Primary Completion Date
2019-12-15
Status
TERMINATED
relationships
The graph out of here
drug
Patients with Schizophrenia
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia
indication
Schizophrenia
indication